1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Takei Y, Suzuki M, Ohwada M, Saga Y, Kohno
T, Machida S and Sato I: A feasibility study of paclitaxel and
carboplatin therapy in Japanese patients with epithelial ovarian
cancer. Oncol Rep. 10:951–955. 2003.PubMed/NCBI
|
3
|
Sugiyama T, Kamura T, Kigawa J, Terakawa
N, Kikuchi Y, Kita T, Suzuki M, Sato I and Taguchi K: Clinical
characteristics of clear cell carcinoma of the ovary: A distinct
histologic type with poor prognosis and resistance to
platinum-based chemotherapy. Cancer. 88:2584–2589. 2000.PubMed/NCBI
|
4
|
Machida H, Matsuo K, Yamagami W, Ebina Y,
Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T and Mikami
M: Trends and characteristics of epithelial ovarian cancer in Japan
between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol.
153:589–596. 2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Mahdi H, Moslemi-Kebria M, Levinson KL,
Gojayev A, Lockhart D, Ali-Fehmi R and Munkarah AR: Prevalence and
prognostic impact of lymphadenectomy and lymph node metastasis in
clinically early-stage ovarian clear cell carcinoma. Int J Gynecol
Cancer. 23:1226–1230. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Takano M, Sugiyama T, Yaegashi N, Suzuki
M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, et
al: The impact of complete surgical staging upon survival in
early-stage ovarian clear cell carcinoma: A multi-institutional
retrospective study. Int J Gynecol Cancer. 19:1353–1357.
2009.PubMed/NCBI View Article : Google Scholar
|
7
|
Takei Y, Takahashi S, Machida S, Taneichi
A, Yoshiba T, Takahashi Y, Yoshida C, Saga Y, Matsubara S and
Fujiwara H: Impact of the number of removed lymph nodes on
recurrence-free survival in stage I ovarian clear cell carcinoma.
Int J Clin Oncol. 23:930–935. 2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargen D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
9
|
Kanda Y: Investigation of the freely
available easy-to-use software 'EZR' for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
10
|
Harter P, Sehouli J, Lorusso D, Reuss A,
Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, et
al: A randomized trial of lymphadenectomy in patients with advanced
ovarian neoplasms. N Engl J Med. 380:822–832. 2019.PubMed/NCBI View Article : Google Scholar
|
11
|
Yamazaki H, Todo Y, Shimada C, Takeshita
S, Minobe S, Okamoto K, Yamashiro K and Kato H: Therapeutic
significance of full lymphadenectomy in early-stage ovarian clear
cell carcinoma. J Gynecol Oncol. 29(e19)2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Magazzino F, Katsaros D, Ottaiano A,
Gadducci A, Pisano C, Sorio R, Rabaiotti E, Scambia G, Cormio G,
Scarampi L, et al: Surgical and medical treatment of clear cell
ovarian cancer: Results from the multicenter Italian Trials in
Ovarian Cancer (MITO) 9 retrospective study. Int J Gynecol Cancer.
21:1063–1070. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Kajiyama H, Suzuki S, Yoshikawa N,
Tamauchi S, Shibata K and Kikkawa F: The impact of systematic
retroperitoneal lymphadenectomy on long-term oncologic outcome of
women with advanced ovarian clear-cell carcinoma. J Gynecol Oncol.
31(e47)2020.PubMed/NCBI View Article : Google Scholar
|
14
|
Nasioudis D, Latif NA, Haggerty AF,
Giuntoli Ii RL, Kim SH and Ko EM: Outcomes of comprehensive
lymphadenectomy for patients with advanced stage ovarian carcinoma
and rare histologic sub-types. Int J Gynecol Cancer. 31:1132–1136.
2021.PubMed/NCBI View Article : Google Scholar
|
15
|
Takano M, Kikuchi Y, Yaegashi N, Kuzuya K,
Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, et al:
Clear cell carcinoma of the ovary: A retrospective multicentre
experience of 254 patients with complete surgical staging. Br J
Cancer. 94:1369–1374. 2006.PubMed/NCBI View Article : Google Scholar
|
16
|
Mueller JJ, Holzapfel M, Han CH, Santos K,
Gunderson C, Moore K, Erickson B, Leath CA III, Diaz E, Walsh C, et
al: Staging lymphadenectomy in patients with clear cell carcinoma
of the ovary. Int J Gynecol Cancer. 26:120–124. 2016.PubMed/NCBI View Article : Google Scholar
|